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ABSTRACT
Mesenchymal stromal cells (MSCs) are immunomodulatory and tissue homeostatic cells that have
shownbeneficial effects in kidneydiseases and transplantation. Perivascular stromal cells (PSCs) iden-
tifiedwithin several different organs share characteristics of bonemarrow-derivedMSCs (BM-MSCs).
These PSCsmay also possess tissue-specific properties and play a role in local tissue homeostasis.We
hypothesized that human kidney-derived PSCs (hkPSCs) would elicit improved kidney repair in com-
parison with BM-MSCs. Here we introduce a novel, clinical-grade isolation method of hkPSCs from
cadaveric kidneys by enriching for the perivascular marker, NG2. hkPSCs show strong transcriptional
similarities to BM-MSCs but also show organotypic expression signatures, including the HoxD10 and
HoxD11 nephrogenic transcription factors. Comparable to BM-MSCs, hkPSCs showed immunosup-
pressive potential and, when cocultured with endothelial cells, vascular plexus formation was sup-
ported, which was specifically in the hkPSCs accompanied by an increased NG2 expression. hkPSCs
did not undergo myofibroblast transformation after exposure to transforming growth factor-b, fur-
ther corroborating their potential regulatory role in tissuehomeostasis. Thiswas further supportedby
the observation that hkPSCs induced accelerated repair in a tubular epithelial wound scratch assay,
whichwasmediated through hepatocyte growth factor release. In vivo, in a neonatal kidney injection
model, hkPSCs reintegrated and survived in the interstitial compartment, whereas BM-MSCs did not
show this potential. Moreover, hkPSCs gave protection against the development of acute kidney in-
jury in vivo in a model of rhabdomyolysis-mediated nephrotoxicity. Overall, this suggests a superior
therapeutic potential for the use of hkPSCs and their secretome in the treatment of kidney diseases.
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SIGNIFICANCE
The present study provides a novel clinical-grade isolationmethod of human kidney-derived perivas-
cular stromal cells (hkPSCs). The hypothesis was that, due to tissue-specific imprinting, hkPSCs are
more potent in renal repair compared to human bone marrow-derived mesenchymal stromal cells.
The present study shows that hkPSCs indeed show distinct functional properties with respect to ep-
ithelial wound healing, interstitial integration, and amelioration of kidney injury. Therefore, these
results suggest significant potential for hkPSCs as therapeutic candidates for the treatment of kidney
diseases.
INTRODUCTION
Mesenchymal stromal cells (MSCs) are immune
modulatory and antifibrotic cells originally iso-
lated from the bonemarrow (BM) and are charac-
terized by their spindle-shaped morphology and
ability to adhere to plastic. BM-MSCs are able
to differentiate into fat, bone, and cartilage and
express the stromal markers CD73, CD90, and
CD105 while being negative for CD34 and CD45
[1, 2]. In several experimental models of kidney
disease (among others, cisplatin, glycerol, and
ischemia-induced injury), MSC treatment en-
hanced tissue repair and reduced fibrosis [3, 4].
In a transplantation model, MSC therapy could
prolong graft survival, and a regulatory T-cell-
dependent tolerance was observed [5]. These
promising results led to the first clinical trials with
BM-MSCs in renal transplantation. Although the
group sizes were small and the studies were
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MSC therapy, the first results suggest an immunomodulatory
effect of BM-MSC therapy [6–9].
Previously, it has been shown that perivascular stromal cells
positive for NG2, CD146, and PDGF-R-b with characteristics sim-
ilar to BM-MSCs exist within many different solid organs, includ-
ing skeletal muscle, pancreas, adipose tissue, and placenta [10].
Because of the perivascular location of these cells, close interac-
tion is possible with several cell types, including endothelial cells,
epithelial cells, residentmacrophages, dendritic cells, and recruited
inflammatory cells. Therefore, these cells aremost likely important
for tissue homeostasis and control of repair processes and inflam-
mation [11].
MSC-like cells could also be isolated from murine kidneys on
the basis of Sca-1 expression. These renal Sca1+Lin2CD452 cells
showed a unique phenotype and immunomodulatory potential
[12–14]. Murine kidney colony-forming cells (kCFU-F) were also
Sca-1+, and although these kCFU-F have a comparable stromal
marker expression and trilineage differentiation potential in com-
parison with BM-MSCs, there is a distinct gene and protein ex-
pression profile [15]. This suggests that although kCFU-F and
BM-MSCsmay look similar, functionally theremaybedifferences.
Li et al. showed that these cells are indeed different from BM-
MSCs [16]. In particular, the cell fraction isolated on the basis
of expression of HoxB7, a collecting duct marker, was able to un-
dergo epithelial-to-mesenchymal transition, and upon delivery
into neonatal mice kidneys, these cells integrated back into the
collecting duct, whereas BM-MSCs lacked this capacity [16].
We hypothesized that perivascular stromal cells can also be
isolated from the human kidney (hkPSCs) in a clinical-grade man-
ner and that these cells have tissue-specific functions. Extensive
characterizationof hkPSCs, both in vitro and in vivo, showacapac-
ity for these cells to stabilize endothelial cells, reduce renal injury,
and support tubular repair, the latter to a greater extent thanBM-
MSCs, suggesting indeed organotypic properties.
MATERIALS AND METHODS
Isolation and Expansion of Clinical-Grade Human
Kidney-Derived Perivascular Stromal Cells
Cells were isolated from human transplant-grade kidneys dis-
carded for surgical reasons by using clinical-grade protocols, en-
zymes, and products. Research consent was given for all kidneys,
and the study was approved by the local medical ethical commit-
tee and the ethical advisory board of the consortium.
Kidneys were flushed with University of Wisconsin (UW)
cold storage solution (Bridge to Life, Elkhorn, WI, http://www.
bridgetolife.com) containing heparin (Leo Pharma, Ballerup,
Denmark, http://www.leo-pharma.us) directly after surgery and
stored on ice. Within 30 hours, kidneys were flushed again with
UW, and the perirenal fat and kidney capsule were removed.
The renal artery was cannulated, and the kidney was perfused
via a pump-driven (Masterflex Applikon, Schiedam, The Nether-
lands, http://www.masterflex.nl) recirculation systemat 37°with
Dulbecco’s modified Eagle medium (DMEM)-F12 (Lonza, Basel,
Switzerland, http://www.lonza.com) at 300ml perminute. After-
ward the kidneywas perfusedwith collagenase (2,500 units, NB1;
Serva, Heidelberg, Germany, http://www.serva.de) and DNAse
(2.5 ml Pulmozyme; Genentech, San Francisco, CA, http://
www.gene.com) at 37°C with a flow of 300 ml per minute. After
approximately 30 minutes, the tissue was digested, and after
gentle massage the resulting cell suspension was collected and
washed in DMEM-F12 containing 10% fetal calf serum. Cells were
theneitherdirectly put into cultureor frozen in liquidnitrogen. The
complete standard operation procedure (SOP) for the isolation
procedure can be found in the supplemental online data.
Kidney cell suspensions were cultured in alphaMEM (aMEM;
Lonza) containing 5% platelet lysates, glutamine (Lonza), and
penicillin/streptomyzine (Lonza), and cells were cultured in tis-
sue culture flasks until confluence was reached. At passage 1,
cells were trypsinized, and NG2 cell enrichment was performed
using MACS, according to manufacturer’s protocol (Miltenyi Bio-
tech, Gladbach, Germany, http://www.miltenyibiotec.com). The
NG2-positive fraction was cultured in aMEM containing 5%
platelet lysate. The cultures were maintained at 37°C and 5%
carbon dioxide. Half the medium was refreshed twice a week.
When the cells reached confluence, the cells were collected us-
ing trypsin (Lonza) and replated at 43 103 cells per cm2. Exper-
iments were performedwith fluorescence-activated cell sorting
(FACS)-confirmed homogeneous NG2-positive hkPSCs between
passages 4 and 8, cultured in aMEM 5% platelet lysate unless
stated differently.
Isolation and Expansion of Human Bone Marrow-
Derived Mesenchymal Stromal Cells
Ethical committee approval and written consent from the donors
was obtained for the aspiration of human bonemarrow. Heparin-
ized bone marrow was aspirated under local or general anesthe-
sia. Themononucleated cell fractionwas isolated by Ficoll density
gradient separation and plated in tissue culture flasks at a density
of 1603 103mononucleated cells per cm2 inaMEM (Lonza), sup-
plemented with penicillin/streptomycin (Lonza) and 5% platelet
lysate. The cultures were maintained at 37°C, 5% carbon dioxide.
Half themediumwas refreshed twice aweek.When theMSC col-
onies or cultures reached confluence, the cells were collected
using trypsin (Lonza) and replated at 43 103 cells per cm2. Exper-
iments were performed between passages 4 and 8.
Morphology and Immunophenotype Analysis
The expanded cell populations were characterized by morphol-
ogy (spindle-shaped cells), which was imaged with an inverted
bright-field microscope (Leica DFC 295; Leica Biosystems, Wet-
zler, Germany, http://www2.leicabiosystems.com/). For immu-
nophenotyping, the cells were stained for NG2, PDGF-R-b,
CD146, CD73, CD90, CD105, CD31, CD34, CD45, CD56, human leu-
kocyte antigen (HLA) class I (ABC), andHLA class II (DR). All specific
fluorochrome-labeled antibodies and isotype controls were pur-
chased from BD Bioscience (Franklin Lakes, NJ, https://www.
bdbiosciences.com), except for CD105 (Ancell Corporation, Still-
water, MN, http://www.ancell.com).
Microarray Sample Preparation and Data Analysis
RNA was isolated from biological triplicates using Trizol re-
agent (Thermo Fisher Scientific Life Sciences, Waltham, MA,
http://www.thermofisher.com) and the RNeasy kit (Qiagen,
Hilden, Germany, https://www.qiagen.com), according to
the manufacturer’s protocol. The quality and quantity of
RNA were assessed with a Nanodrop spectrophotometer
(Thermo Fisher Scientific Life Sciences) and a Bioanalyzer (Agi-
lent Technologies, Santa Clara, CA, http://www.agilent.com).
Gene expression profiling was performed by Aros Applied
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Biotechnology (Aarhus, Denmark, http://arosab.com). cDNA
and cRNA synthesis, labeling, and subsequent hybridization
on the human HT12 V4 gene expression beadchips (Illumina
Inc., San Diego, CA, http://www.illumina.com) were per-
formed according to the manufacturer’s protocols. The bead-
chips, targeting more than 47,000 gene transcripts, were
scanned with the iSCAN system (Illumina Inc.), and fluores-
cence intensities were uploaded into GenomeStudio Software
(Illumina Inc.). Genes with a detection p value of ..05 for all
samples were excluded. Average signals of .200 in either
the BM-MSCs or hKPSCs were considered above background
levels. Subsequent data were quantile normalized, and the
Pearson’s correlation coefficient was calculated (r2). Differen-
tial expression was analyzed with the gene expression module
of Genome Studio (Illumina). For the table of the top differen-
tial expressed genes, we sorted genes on the highest difference
score. Differential scores were calculated from the differential
p value in Illumina software with the following formula: Diff-
Score = 103 sgn (mcond2 mref)3 log 10 p. False discovery
rates were calculated according to Benjamini and Hochberg for
a total number of 8,462 transcripts [17]. All genes in the top five
up- and downregulated genes showed significant differential
expression. The delta average signal of BM-MSCs versus hkPSCs
was set to 200 (which is the threshold of the measurement), and
2,600 genes selected were analyzed for clustering in R software.
Clustering in R software was also performed for 27 homeobox
genes. Expression of HoxD10 and HoxD11 was confirmed by
quantitative real-time polymerase chain reaction (qPCR) in
duplo of the same biological triplicates. qPCRwas performed us-
ing iQ SYBR Green Supermix on iCycler real-time detection sys-
tem (Bio-Rad, Hercules, CA, http://www.bio-rad.com), as per
the manufacturer’s instructions. The real-time PCR primers of
HoxD10 are AGACAGTTGGACAGATCCGAA(fw) and CGAAAT-
GAGTTTGTTGCGCTTAT (rv) andofHoxD11areTCGACCAGTTCTAC-
GAGGCA (fw) and AAAAACTCGCGTTCCAGTTCG (rev). The
amplification reaction volume was 12.5 ml in total, consisting of
6.25 ml iQ SYBR Green PCR master mix, 0.5 ml primers, 2.5 ml
cDNA, and 3.25 ml water. Messenger RNA (mRNA) level was nor-




chondrogenic medium according to the manufactures protocols
(Lonza). After 3 weeks of culture, in the adipogenic differentiation
assay, lipid droplets were stained using Oil Red O, and in the oste-
ogenicdifferentiationassay, calciumdepositionswere stainedwith
AlizarinRed. For chondrogenic differentiation, cell pelletswere for-
malin fixed (4% paraformaldehyde [PFA] O/N) and embedded in
paraffin. Subsequently, 5-mm sections were deparaffinized, rehy-
drated, and stained with 1% toluidine blue for 20 minutes. All dif-
ferentiation assays were analyzed with an inverted bright-field
microscope (Leica DFC 295; Leica Biosystems).
Cytokine Excretion, Peripheral Blood Mononuclear Cell
Isolation, and Proliferation Assay
hkPSCs and BM-MSCs of 3 different donors were plated in flat-
bottom 96-well plates, and after 5 days of culture, supernatants
were harvested, and cytokine expression profiles were deter-
mined in the supernatant with the Bio-Plex Human Cytokine
17-Plex Panel, following the manufacturer’s instructions (Bio-
Rad). Cytokines in culture medium were also measured as a neg-
ative control.
Peripheral blood mononuclear cells (PBMCs) were isolated
frombuffy coats of healthy blood donors by density gradient cen-
trifugation using Ficoll-isopaque and frozen in liquid nitrogen un-
til use. Cultured hkPSCs and BM-MSCs (passages 6–8) of 3
different donors were plated in flat-bottom 96-well plates (Co-
star; Sigma-Aldrich, St. Louis, MO, https://www.sigmaaldrich.
com)andallowed toattachovernight inDMEM-F12with10%nor-
mal human serum (NHS). Culture in 10%NHSwas chosen because
Figure 1. Isolation method of human kPSCs. (A): NG2 is expressed in the human kidney mainly around the arteries, arterioles and afferent
and efferent arterioles of the glomerulus. CD271 (B) and PDGF-R-b (C) are also expressed within the glomeruli and around the peritubular
capillaries. (D): Schematic representation of the isolation method. In order to obtain NG2-positive hkPSCs, human kidneys are continuously
perfused with digestive enzymes to single kidney cells. Afterward, crude kidney cell suspensions were cultured on plastic for selection
on plastic adherence and subsequently sorted for NG2 positivity, resulting in the appearance of spindle- shaped cells. Scale bars = 50 mm
([A], left), 20 mm ([A], right), and 50 mm (B, C). Abbreviations: kPSCs, kidney-derived perivascular stromal cells; PDGF-R-b, platelet-derived
growth factor-receptor-b.
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platelet lysates are able to suppress PBMC proliferation on their
own (data not shown). PBMCs were stimulated with anti-CD3/
anti-CD28 Dynabeads (Thermo Fisher) and were seeded in tripli-
cateata concentrationof13105 cells perwell. Stromal cellswere
added to the PBMCproliferation assay in a ratio of 1:4 and1:8. 3H-
thymidine (0.5 mCi) was added after 5 days and 3H-thymidine in-
corporation was determined after 16 hours as a measure of
proliferation.
Figure2. CharacterizationofhumankPSCs. (A):HumankPSCshaveamorphology similar to thatofBM-MSCsandarepositive forNG2andPDGF-R-b,
as is shown with confocal images (B). (C): Growth characteristics of human kPSCs. (D): Representative FACS analysis shows that human kPSCs are
positive for the pericytic markers NG2, PDGF-R-b, and CD146 and for the MSC markers CD73, CD90, and CD105, and are negative for CD31,
CD34, CD45, and CD56. Human kPSCs express type I human leukocyte antigen (HLA-ABC) and are negative for type II HLA (HLA-DR). (E):Mean fluo-
rescent intensity of the differentmarkers (n = 3 donors). (F): Trilineage differentiation. Human kPSCs differentiate into bone and cartilage but not into
adipocytes. Scale bars = 200 mm (A, F) and 20 mm (B). Abbreviations: BM-MSC, bone marrow-derived mesenchymal stromal cells; FITC, fluorescein
isothiocyanate; HLA, human leukocyte antigen; kMSC, kidney-derived mesenchymal stromal cells; kPSC, kidney-derived perivascular stromal cells;
PDGF-R-b, platelet-derived growth factor-receptor-b.
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Figure 3. Transcriptomeanalysis of humankPSCs in comparisonwithBM-MSCs. (A):Whencomparing all transcripts (35,000), BM-MSCs andhuman
kPSCs show a similar expression profile, as is depicted by a Pearson correlation score of 0.9625. (B):Human kPSCs and BM-MSCs show a hierarchical
clusteringper cell type. (C):Hierarchical clustering isalsoobserved inHoxgenes. (D):Differential expressionofHoxD11andHoxD10,homeobox factors
important for nephrogenesis, as confirmed by polymerase chain reaction. (GEO accession GSE77227, http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE77227.) Abbreviations: BM-MSC, bone marrow-derived mesenchymal stromal cells; GAPDH, glyceraldehyde-3-phosphate de-
hydrogenase; kPSC, kidney-derived perivascular stromal cells.
Leuning, Reinders, Li et al. 5
www.StemCellsTM.com ©AlphaMed Press 2016
ID: srinivasanv Time: 19:35 I Path: Z:/SCTM/Vol00602/170027/Comp/APPFile/JW-SCTM170027
i i i l 409
. ll . Oc 2016 The Authors
STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
Vascular Plexus Assay
Human umbilical cords were obtained from the Leiden University
Medical Center (Leiden, TheNetherlands) after informed consent
from the parents.
Human umbilical vein endothelial cells (HUVECs) were isolated
according to Jaffe et al. [18], with minor modifications: trypsin/EDTA
(Sigma-Aldrich)was used to enzymatically detach the endothelial cells
from the vein, and the endothelial cells were cultured on fibronectin-
coated flasks (isolated from bovine plasma; Sigma-Aldrich)
and refreshedtwiceaweekwithEC-medium,consistingofM199Earl’s
salt with L-glutamine (Thermo Fisher), supplemented with 10% (v/v)
fetal calf serum (PAA Cell Culture Company, Pasching, Austria, www.
paa.com), penicillin/streptomycin (PAA Cell Culture Company), 1,000
IU of heparin (Leo Pharma), and 25 mg bovine pituitary extract
(BPE) (Thermo Fisher). HUVECs were used at passages 2–3 [18].
Stromal cells and HUVECS were cocultured in a 96-well plate
(Costar; Sigma-Aldrich) for 1 week in a 4:1 ratio, as has been de-
scribed previously [19]. After 1 week, cells were fixated for 10
minutes with ice-cold methanol (100%), and endothelial sprout-
ingwasvisualizedwithCD31 immunofluorescence (Zeiss LSM500;
BD Bioscience). The percentage capillary coverage was analyzed
with ImageJ software. NG2 immunofluorescence (BD Bioscience)
was determined (Zeiss LSM500) and quantified as mean fluores-
cent intensity in Image J.
Transforming Growth Factor-b Stimulation
hkPSCs andBM-MSCswere seeded in a density of 200,000 cells in a
6-well plate and stimulated for 48 hours with 10 ng/ml transform-
ing growth factor (TGF)-b1 (Preprotech, London, U.K., https://
www.peprotech.com). Cells were subsequently trypsinized, per-
meabilizedwith 0.1% saponine, and labeledwitha-smoothmuscle
actin (a-SMA;BDBioscience).a-SMAexpressionwasanalyzedwith
flow cytometry, and mean fluorescent intensities were calculated
(Kaluza; Beckman Coulter, Brea, CA, http://ca.beckman.com).
Kidney Epithelial Wound Scratch Assay
hkPSCs and BM-MSCs of 3 different donorswere plated in a den-
sity of 200,000 cells per well in a 6-well culture plate (Costar;
Sigma-Aldrich) and cultured for 48 hours. HK2 cells were seeded
in proximal tubular epithelial cells medium, consisting of a 1:1
ratio of DMEM and Ham’s F-12 (Lonza), supplemented with in-
sulin (5mg/ml), transferrin (5mg/ml), selenium (5 ng/ml), hydro-
cortisone (36 ng/ml), triiodothyrinine (40 pg/ml), and epidermal
growth factor (10 ng/ml) (Sigma-Aldrich) in a density of 500,000
cells per well in a 6-well cell culture plate (Costar) and cultured
until confluent. A scratch wound was created in the monolayer
ofHK2 cells using a 200-ml pipette tip. After the scratch, cellswere
washedwith phosphate-buffered solution (PBS) and provided ei-
ther with fresh medium (aMEM 5% PL) or with complete condi-
tioned medium from either hkPSCs or BM-MSCs. Scratches were
imaged at 4, 7, 14, and 28 hours at the same position in duplicates
with an inverted bright-field microscope (Leica DFC 295; Leica
Biosystems). The scratch area was measured at each time point
using ImageJ software, and the percentage wound closure was
calculated.
Growth factors in the conditionedmedium of kPSCs weremea-
suredusing a custom-madegrowth-factor panel, following theman-
ufacturer’s instructions (R&D Systems, Minneapolis, MN, https://
www.rndsystems.com). The hepatocyte growth factor (HGF)-
receptor was blocked with an HGF receptor/c-MET antibody (R&D
Systems) in a concentration of 1 mg/ml 1 hour before the wound
scratch assay and after adding the hkPSC supernatant. In the control
conditions an isotype antibody (goat IgG, homemade) was added.
Neonatal Injection Model
Animal experiments were approved by the University of Queens-
land animal ethics committee and adhered to theAustralian Code
of Practice for the Care andUse of Animals for Scientific Purposes.
Neonates of outbred CD1 mice were used for neonatal injection.
Table 1. Top five differentially expressed genes comparing BM-MSCs to hkPSCs
Gene name Symbol Average signal BM-MSC (SD) Average signal hkPSC (SD) Fold increase DiffScore
Top five enriched genes, hkPSC
Endothelin 1 EDN1 206 (32) 2,205 (238) 10.7 342.9
Tissue factor pathway
inhibitor 2
TFPI2 329 (97) 3,446 (609) 10.5 342.9
Regulator of G-protein
signaling 4
RGS4 2,500 (1,282) 24,091 (1,615) 9.6 342.9
Homeobox D11 HOXD11 ,200 (12) 1,522 (109) 8.4 342.9
Myosin, heavy chain 10,
nonmuscle
MYH10 3,322 (667) 21,945 (1,272) 6.6 342.9
Top five enriched genes, BM-MSC
Latent transforming growth
factor b binding protein 2
LTBP2 7,825 (449) 1,818 (318) 24.3 2340.5
Odd Oz/ten-m homolog 4 ODZ4 1,745 (55) 482 (28) 23.6 2340.5
HtrA serine peptidase 1 HTRA1 9,384 (356) 2,833 (621) 23.3 2299.8
Fibronectin type III domain
containing 1
FNDC1 12,278 (1,828) 189 (50) 265.1 2256.5
Early B-cell factor 3 EBF3 931 (84) 273 (51) 23.4 2243.2
Upperhalf: Increasedgeneexpression in kPSC, sortedon thebasis of differentialp values. Lowerhalf:Upregulatedgenes inBM-MSCs. Average signal for
biological triplicates is shown. Only samples with a detection p , .05 and with a fluorescent intensity.200 (background levels) are shown. All
differentially expressed genes show a significant p value after correcting for multiple testing. Abbreviations: BM-MSCs, bone marrow-derived
mesenchymal stromal cells; hkPSCs, human kidney-derived perivascular stromal cells.
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Figure 4. Immunomodulatory and vascular stabilization function of human kPSCs. (A): Cytokine expression profile of unstimulated human
kPSCs andBM-MSCs. (B):Peripheral bloodmononuclear cells (PBMCs) suppression assay. Proliferation of activated PBMCswasdecreasedwhen
cocultured with both hkPSCs and BM-MSCs in a dose-dependent matter. (Ratio is number of activated PBMCs vs. number of MSCs.) (C):When
human umbilical vein endothelial cells are coculturedwith either human kPSCs or BM-MSCs, endothelial networks were formed, whichwas not
observed in monoculture. There were no significant differences in vascular plexus formation comparing coculture with BM-MSCs or human
(Figure legend continues on next page.)
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hkPSCs and BM-MSCs of 3 and 2 different donors, respectively,
were injected into the neonatal kidneys at postnatal day 1 by us-
ing amicroinjection pipet in a protocol adapted from the protocol
previously described [16]. In short, neonates were anesthetized
and a small incision in the skinwasmade. Cells were resuspended
in PBS and mixed with Fluoresbrite Yellow Green microspheres
(2.0 mm; Polyscience, Niles, IL, https://www.polyscience.com)
in a ratio of 1:50 for identification of injection sites in the neonatal
kidney. Using an Eppendorf microinjector, we injected cells into
the kidney through the muscle layer in a volume of 300 nl, corre-
sponding with 3,000–5,000 cells. Kidneys were harvested at 4
days postinjection. In total, sevenmicewere analyzed: threemice
with hkPSCs from three different donors; three mice with BM-
MSCs from two different donors, and one sham-operatedmouse.
In all mice, injection into the kidney was confirmed by fluores-
cence of the coinjected microspheres.
Glycerol-Induced Rhabdomyolysis Model of Acute
Kidney Injury
Animal experiments were performed in accordance with institutional,
regional, and state guidelines and in adherence to the Italian National
Institutes of Health Guide for the Care andUse of Laboratory Animals.
Rhabdomyolysis-inducedacutekidneyinjurywasstudiedin6-week-old
maleC57Bl/6mice (EnvigoRMSSrl, SanPietroalNatisone, Italy,http://
www.envigo.com)by intramuscular injectiononday0with hypertonic
glycerol (8ml/kgbodyweightofa50%glycerol solution;Sigma-Aldrich)
into the inferior hind limbs, as has been described previously [20].
hkPSCs were labeled with the PKH26 Red Fluorescence Cell Linker
Kit (Sigma-Aldrich), according to the manufacturer’s instructions, and
labeling efficiency was verified by flow cytometry. Cells were acquired
before and after labelingwith aMACSQuant Analyzer FlowCytometer
and analyzed with MACSQuantify software (Miltenyi Biotec GmbH).
Cell vitalitywasmonitoredusingpropidium iodide staining, andweob-
served.95% living cells. Themice received PKH26-labeled hkPSC fol-
lowing one of two injection routes. For subcapsular injection, 4 hours
followingkidney injury,mice (n=6 forbloodureanitrogen [BUN]mea-
surement,n=4 for confocalmicroscopy)wereanesthetizedwithAver-
tin (2,2,2-tribromoethanol,250mg/kg;Sigma-Aldrich)andsubjectedto
dorsal incision on the left side to exteriorize the left kidney. A 1-mm
incisionwasmade in the capsule of the kidney, and 750,000 cellswere
injected into25-ml of sterilePBSwithaHamiltonsyringeequippedwith
a 27-G blunt-ended needle. After cell infusion, the kidney capsule was
cauterizedwith an electric scalpel, and the dorsal incisionwas sutured.
The mouse was rehydrated with subcutaneous injection of 500ml sa-
line solution andmaintained in awarm environment for 2 hours post-
surgery. Controlmicewere injectedwith saline solution (n = 6 for BUN
measurement, n = 4 for confocal microscopy). For intravenous retro-
orbital injection, 4 hours and 24 hours following kidney injury, mice
(n=6 forBUNmeasurement,n=4 forconfocalmicroscopy)wereanes-
thetized with isoflurane (Aerrane; Baxter, Rome, Italy, http://www.
baxteritalia.it) and injected retro-orbitally through the venous plexus
with750,000cells in150mlofsterilePBSeachtimeusinga27-Gneedle.
Controlmicewere injectedwithsalinesolution (n=8forBUNmeasure-
ment, n = 4 for confocal microscopy).
Blood samples were obtained from the submandibular ve-
nous sinus at days 0, 4, 6, and 14, and BUN levels were measured
by Reflotron System (Roche Diagnostics, Rotkreuz, Switzerland,
www.roche.com). Four animals per group were sacrificed at
day 6, and kidney, lungs, and liver were harvested for confocal
microscopy.
Immunofluorescence of Kidney Sections
In the neonatal injection model, kidney samples were fixed in 4%
PFA, followedby30%sucroseovernight andembedded in TissueTek
OCT compound (Sakura Finetek, Torrance, CA, http://www.
sakura-americas.com). Samples were frozen in liquid nitrogen
and stored at 280°C. Ten-micrometer-thick sections were cut
and postfixed with 4% PFA for 10 minutes at room temperature.
Stainings were performed using the manufacturer’s protocol
(Mouse on Mouse kit; Vector Laboratories, Burlingame, CA,
https://vectorlabs.com; Brunschwig Chemie, Amsterdam, The
Netherlands, http://www.brunschwig.nl). Samples were stained
with antibodies against human mitochondria, nuclei, and colla-
gen IV (Abcam, Cambridge, U.K., http://www.abcam.com) and
analyzed using a TCS SP8 laser confocal microscope (Leica Bio-
systems). In the rhabdomyolysis-induced acute kidney injury
model, confocal microscopy was performed on 10- mm sections
of renal frozen tissues using a TCS SP5-II laser confocal micro-
scope (Leica Biosystems). Staining for fluorescein isothiocyanate
(FITC)-labeled Dolichos biflorus agglutinin and FITC-labeled Lotus
tetragonolobus agglutinin (Vector Laboratories) was performed
following manufacturer’s instructions. To-pro-3 (Thermo Fisher)
was used for counterstaining nuclei.
Statistical Analysis
Differences between two groups were analyzed using an un-
paired two-sample Student t test. When more than two groups
were analyzed, a two-wayanalysis of variance testwasusedwith
Bonferroni’s comparison test as a post hoc test. Differences
were considered statistically significantwhenp, .05. Data anal-
ysis was performed using GraphPad Prism, version 5.0 (Graph-
pad Prism Software, Inc., La Jolla, CA, https://www.graphpad.
com). For statistical analysis of the microarray data, p values
were corrected for multiple testing according to Benjamini
and Hochberg [17].
(Figure legend continued from previous page.)
kPSCs (D). (E):When human kPSCs were cocultured with endothelial cells, the expression of NG2 was increased; this was not seen with BM-
MSCs. (F):Quantification of NG2 positivity with and without coculture with endothelial cells. (G): No differences were observed in excretion of
vascular growth factors by humankPSCs in comparisonwith BM-MSCs. (H):After stimulation of human kPSCswith 10ng/ml TGF-b, therewas no
increase in a-smooth muscle actin (SMA) expression. This was not observed for BM-MSCs. Isotype control (white), unstimulated cells (red), cells
stimulatedwith10ng/mlTGF-b (green). (I):Quantificationofa-SMApositivity;n=3biological triplicates.Scalebar=50mm (C, E).p,p, .05;pp,p,
.001. Abbreviations: Ang, angiopoietin; bmMSC, BM-MSC, bone marrow-derived mesenchymal stromal cells; capp, capillary coverage; G-CSF, gran-
ulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; HUVEC, human umbilical vein endothelial cells; IFN,
interferon; IL, interleukin; kPSC, kidney-derived perivascular stromal cells; MIP-1, macrophage inflammatory protein 1; MCP-1, monocyte chemoat-
tractant protein 1; n.s., nonsignificant; PBMC, peripheral bloodmononuclear cells; TGF, transforming growth factor; TNF-a, tumor necrosis factor-a;
VEGF, vascular endothelial growth factor.
8 Human kPSCs for Kidney Regenerative Medicine
©AlphaMed Press 2016 STEM CELLS TRANSLATIONAL MEDICINE
ID: srinivasanv Time: 19:35 I Path: Z:/SCTM/Vol00602/170027/Comp/APPFile/JW-SCTM170027
412 Human kPSCs for Kidney Regenerative Medicine
Oc 2016 The Authors STE ELLS RA SLATI L E I I
STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
Figure5. HumankPSCsareable toenhanceepithelial repair inawound scratchassay. (A):Bright-field images showing representative imagesof
the wound scratch assay in control medium or conditionedmedium of human kPSCs and BM-MSCs across a time period of 14 hours. (B):Quan-
tificationof the rateofwoundclosure in all three conditions after 0, 4, 7, 14, and28hours. Thewoundcloses significantly faster in thepresenceof
human kPSC-conditionedmedium in comparisonwith BM-MSC-conditionedmediumor control medium. (C): Excretion of growth factors in the
conditioned medium. HGF is excreted by human kPSCs but not by BM-MSCs. (D): Bright-field images showing representative images of the
(Figure legend continues on next page.)
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RESULTS
A Novel Method to Isolate Clinical-Grade Human
Kidney-Derived Perivascular Stromal Cells
InordertoevaluatewhetherhkPSCsareapotentialnewcell sourcefor
use incell therapy to treat kidneydisease inaclinical setting,wechose
to develop a clinical-grade acceptable SOP with the use of clinical-
gradematerials and enzymes. This protocol is developed on the basis
of thepancreatic islet isolationprotocol currently inuse for clinical ap-
plication inour center [21]. Perivascular stromal cellswere isolatedon
the basis of NG2 expression. NG2 is an integralmembrane proteogly-
can that is associated with perivascular cells during vascular morpho-
genesis [22]. Within the human kidney, NG2 is mainly expressed
around the large arteries and the afferent and efferent arterioles
(Fig. 1A). NG2 expression is more restricted than is the expression
of CD271, an enrichment marker for BM-MSCs (Fig. 1B) [23] or of
PDGF-R-b-positive perivascular cells (Fig. 1C). Thesemarkers are also
expressedwithin the glomeruli and around the peritubular capillaries
of the kidney. NG2-positive cells were isolated from a pool of 10
transplant-grade kidneys discarded for surgical reasons. Experiments
wereperformed,andresultsareshownforthreedifferentdonors.The
averagedonoragewas62years,withanaverageestimatedcreatinine
clearance (Cockroft) of 105 ml per minute. In order to isolate NG2-
positivecells,weperfusedthesekidneyswithcollagenasetodissociate
intosinglecells,enrichedonthebasisofplasticadherence,thensorted
on the basis of NG2 expression at the first passage (Fig. 1D).
Characterization ofHumanKidney-DerivedPerivascular
Stromal Cells
NG2-positive hkPSCs showed a bright-field morphology similar to
that of BM-MSCs (Fig. 2A) and, as with BM-MSCs, were positive
for the pericyte markers NG2 and PDGF-R-b, as is shown with con-
focal microscopy (Fig. 2B). Growth characteristics are shown from
flow cytometry-confirmed NG2 homogeneous populations; at
around passage 9, hkPSCs reached senescence (Fig. 2C). In addition
to NG2, hkPSCs were positive for the surface markers PDGF-R-b,
CD146, CD73, CD90, and CD105 while being negative for CD31,
CD34,CD45,andCD56,asdeterminedbyFACS (Fig.2D).Thismarker
expression is robust, as depicted by the mean fluorescent intensity
of cells of three different donors (Fig. 2E). Whereas human BM-
MSCswereable todifferentiate into all three lineages, hkPSCs could
differentiate toward osteocytes and chondrocytes, and no adipo-
genic differentiation was observed (biological triplicates) (Fig. 2F).
Organ-Specific Gene Expression Profile of Human
Kidney-Derived Perivascular Stromal Cells
In order to further compare hkPSCs to BM-MSCs, we performed Illu-
minamicroarrayexpressionprofilingonbiologicaltriplicatesofdifferent
donors. Analysis of expression levels of 35,000 transcripts showed that
most genes showed a similar expression level (Pearson correlation co-
efficient of 0.9625), suggesting high similarity between the two cell
types (Fig. 3A). However, 2,600 genes were differentially expressed,
and hierarchical clustering was able to distinguish on the basis of cell
source (Fig. 3B). Table 1 shows the top five up- and downregulated
genes comparing BM-MSCs and hkPSCs on the basis of differential
p value. The top 50 up- and downregulated genes can be found in
supplemental online Table 1. Interestingly, homeobox factor HoxD11
is in the top five most upregulated genes in hkPSCs. Homeobox tran-
scription factors, which are important in anatomical patterning during
development, showed hierarchical clustering when comparing BM-
MSCs with hkPSCs (Fig. 3C). Homeobox paralogues Hox10 and
Hox11 are important in kidney development [24, 25]. Both genes are
highly expressed in hkPSCs but not in BM-MSCs, as confirmed by
PCR (Fig. 3D). These results indicate that although hkPSCs and BM-
MSCs may display a similar phenotype of surface markers, there are
tissue-specific differences in expression profile between the cell types.
Immunomodulatory Capacity ofHumanKidney-Derived
Perivascular Stromal Cells
One important and extensively studied feature of MSCs is their
anti-inflammatory and immunomodulatory potential. MSCs are
able to regulate proliferation and cytotoxicity of T cells, macro-
phages, and B cells, which are alsomajor players in kidney disease
and transplantation, as has been reviewed elsewhere [26]. There-
fore,we evaluated the immunomodulatory potential of hkPSCs in
comparison with BM-MSCs. Unstimulated human kPSCs and
BM-MSCs showed a similar expression profile for all major cyto-
kines (Fig. 4A). We also evaluated the immunosuppressive ca-
pacity of hkPSCs. In a peripheral blood mononuclear cell
(PBMC) suppression assay, where PBMCswere activated by poly-
clonal CD3/CD28 activation in the absence or presence of stromal
cells, both hkPSCs and BM-MSCs inhibited proliferation in a dose-
dependent manner (Fig. 4B). However, BM-MSCs were more po-
tent in inhibiting proliferation at a lower cell ratio (8:1 PBMCs:
MSC ratio) in comparison with hkPSCs.
Coculture of Endothelial Cells With Human Kidney-
Derived Perivascular Stromal Cells Stabilizes Vascular
Network Formation
To evaluate whether cultured hkPSCs still have pericytic properties,
we cocultured cells with human umbilical vein endothelial cells
(HUVEC). HUVECs were not able to form endothelial sprouts in
monoculture. However, when cocultured with either BM-MSCs or
hkPSCs, vascular plexus formation occurred (Fig. 4C). There were
no significant differences in vascular network formation between
thecell types (Fig.4D). Interestingly,whencoculturedwithendothe-
lial cells, hkPSCs showed an increase in NG2 expression, although
this was not observed with BM-MSCs (Fig. 4E, 4F). Both BM-MSCs
and hkPSCs mainly secreted vascular endothelial growth factor
(VEGF), and there was no difference between the cell types in the
levels of VEGF, angiopoetin 1, and angiopoetin 2 produced (Fig. 4G).
hkPSCs Do not Become Myofibroblasts After
Stimulation With TGF-b
Because stromal cells in general have the capacity to becomemyofi-
broblasts after stimulation with TGF-b, thereby contributing to fibro-
sis, we evaluated whether hkPSCs have this capacity. Interestingly,
(Figure legend continued from previous page.)
wound scratch assaywith andwithoutHGF-Rblocking. (E):Quantificationof the rateofwoundclosureafter0,4,7,12, and24hours;n=3biological
triplicates. p, p , .05; pp, p , .001; ppp, p , .0001. Abbreviations: BM-MSC, bone marrow-derived mesenchymal stromal cell; FGF, fibroblast
growth factor; HGF, hepatocyte growth factor; kPSC, kidney-derived perivascular stromal cell; n.s., nonsignificant; PDGF, platelet-derived growth
factor; t, time.
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Figure 6. Human kPSCs are able to survive and integrate into the kidney interstitium in a neonatal injection method and in a model of acute
kidney injury and give preservation of renal function. (A): Cells and fluorescent microspheres were injected into the kidney of neonatal mice
(postnatal day 1, PND1). (B): Injection into the kidney was confirmed by fluorescent microspheric beads (p). (C): Human kPSCs injected into the
kidneys of neonatal mice (PND1) were localized in the cortical interstitium, as is shown with specific antibodies for human mitochondria and
human nuclei, respectively (arrows). (D): No BM-MSC could be found in the kidney 4 days after injection. (E): BUN measurements after i.v.
injection of human kPSCs in a glycerol-induced rhabdomyolysis model. (F):Human kPSCs were localizedmainly in the interstium of themedulla
(Figure legend continues on next page.)
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stimulationof hkPSCswith TGF-b didnot increasea-SMAexpression,
suggesting that hkPSCs did not become myofibroblasts (Fig. 4H, 4I).
Enhanced Renal Epithelial Wound Repair Capacity of
Human Kidney-Derived Perivascular Stromal Cells
In order to evaluate the effect of hkPSCs on renal tubular epithelial
repair, wemade a scratch in amonolayer of human kidney proximal
tubular epithelial cells (HK2). Under control culture conditions, at
least 28 hours was necessary for 80% wound closure. Interestingly,
when conditioned media from hkPSCs were added, significant clo-
sure was already observed after 4 hours, with 80% of the wound
closed after 7 hours (mean of duplicate experiments from three dif-
ferent donors). Importantly, 14 hours was required to reach an 80%
wound closure in parallel experiments with the conditioned media
fromBM-MSCs(Fig.5A,5B).This showsthathkPSCscanproduce fac-
tors able to better support renal epithelial repair. HGF is most likely
an important factor in this activity becauseHGFwas secreted at high
levels by hkPSCs but not by BM-MSCs, whereas no differences were
observed in the levels of other growth factors (PDGF-AA, PDGF-BB,
endothelin1, fibroblastgrowth factor [FGF]-a, FGF-B) (Fig.5C).More-
over, blocking theHGF receptor on the epithelial cells resulted in de-
creased wound healing (Fig. 5D, 5E).
Interstitial Integration and Survival of Human Kidney-
Derived Perivascular Stromal Cells in the
Neonatal Kidney
Todetermine the role of hkPSCs in kidneydevelopment,we injected
hkPSCs into neonatal mice at postnatal day 1 using microinjection
(Fig. 6A, 6B). Interestingly, at day4postinjection, humankPSCSwere
able to integrate and survive within the cortical, but not themedul-
lary interstitium of the mouse kidney with no evidence of rejection
(Fig. 6C). No such persistencewas observedwhen human BM-MSCs
were injected (Fig. 6D), consistentwith our previous studies [16]. No
integration into tubular structureswas seenwith either human BM-
MSCs or hkPSCs upon injection. The persistence of viable human
hkPSCs for 4dayswithin the renal interstitiumsuggests a differential
integration capacity for this stromal cell type.
Human Kidney-Derived Perivascular Stromal Cells
Integrate in the Renal Interstitium and Improve Renal
Function in a Glycerol-Induced Rhabdomyolysis Acute
Kidney Injury Model
To access the effect of hkPSCs in kidney injury, we injected the cells
inaglycerol-inducedrhabdomyolysisacutekidney injurymodel.We
evaluated the effect of hkPSCs via two routes of administration: re-
nal subcapsular and intravenous. Bloodureumnitrogen (BUN)mea-
surements show that at the peak of acute kidney injury (AKI), renal
functionwas significantly preserved in the hkPSC-treated group, in-
dependentof routeof delivery (Fig. 6E, 6G).After both routes of de-
livery, interstitial integration of the PKH26-labeled hkPSCs was
observedwithin the kidney, although fewer cells were observed af-
ter intravenous injection (0.024760.002 cells per field subcapsular
vs. 0.01646 0.0051 cells per field i.v.). After subcapsular injection,
cells weremainly distributed in an area of 990mmaround the area
of injection. After intravenous injections, most cells were observed
in the medulla region and fewer in the cortex (0.02036 0.006 vs.
0.00956 0.0066) (Fig. 6F, 6H).
DISCUSSION
It has previously been reported that perivascular stromal cells from
several different human organs share featureswithMSCs [10].More
recently, it hasbeen shown that organ-derivedperivascular cellsmay
exhibit tissue-specific functions [27]. Humanmyocardial perivascular
cells, for example, stimulateangiogenic responsesunderhypoxia and
differentiate into cardiomyocytes in vivo, characteristics not seen in
perivascular cells isolated from other tissues [28].
Herewe sought to isolate human kidney-derived perivascular
stromal cells and show that these cells have distinct properties in
comparison with human BM-MSCs. In order to evaluate the func-
tionality of these cells, we studied their interaction with several
different renal cell types, including endothelial cells, proximal tu-
bular cells, and (infiltrating) immune cells. Therewere similarities
between humanBM-MSCs and hkPSCs; however, hkPSCs showed
a distinct mRNA expression profile, did not differentiate into ad-
ipocytes, and displayed a more potent kidney epithelial wound-
healing capacity. Furthermore, hkPSCswere able to integrate into
the interstitium of the developing kidney, whereas BM-MSCs did
not. Finally, hkPSCs could preserve kidney function in a glycerol-
induced rhabdomyolysis model of acute kidney injury.
Because there is a lack of specific markers of MSCs, the Inter-
national Society forCellularTherapyhasproposedcriteria todefine
MSCs. These include plastic adherence; the marker expression of
CD73, CD90, and CD105 while being negative for CD14, CD34,
and CD45; and the capacity to differentiate into bone, cartilage,
and fat in vitro [1]. The hkPSCs we isolated did not fulfill these cri-
teria because there was no adipocyte differentiation. However,
these criteria are based on bone marrow-derived MSCs, and the
lack of this capacitymight actually be beneficial because it has pre-
viously been shown that MSCs injected into the renal artery in a
glomerulonephritismodel can turn intoadipocytes in theglomeruli
accompaniedbyglomerular sclerosis aroundtheseadipocytes [29].
MSCs are important for tissuehomeostasis,most likely via the
secretion of several soluble factors and microvesicles containing,
among others, mRNAs and miRNAs [30, 31]. Indeed, BM-MSC-
conditioned medium is able to accelerate wound healing in vitro
[32, 33] and, in a mouse model of glycerol-induced acute kidney
injury, enhanced recovery in kidney function was observed when
eitherMSCsorMSC-derivedmicrovesicleswere injected [30]. The
same is most likely true for organ-derived perivascular stromal
cells. Conditioned medium from murine kidney MSC-like cells
was able to enhance kidney epithelial wound healing in an in vitro
wound scratch assay [16]. Herewe show that the conditionedme-
dium from human kPSCs elicited accelerated repair in a tubular
epithelial wound scratch assay, suggesting tissue-specific para-
crine signaling. An important factor in this signaling is most likely
hepatic growth factor (HGF), because HGF is highly secreted by
(Figure legend continued from previous page.)
after i.v. infusion and did not integrate in the Lotus tetragonolobus agglutinin-positive proximal tubuli or Dolichos biflorus agglutinin-positive
collection duct (arrows). (G): BUN after subcapsular administration of human kPSCs in a glycerol-induced rhabdomyolysis model. (H): Human
kPSCs integrated in the interstium in the cortex and not in themedulla (arrows). No integration in the tubuli was observed. Scale bars = 500mm
(B) and 50mm (C, D, F, H). Abbreviations: BM-MSC, bone marrow-derived mesenchymal stromal cell; BUN, blood urea nitrogen; kPSC, kidney-
derived perivascular stromal cell.
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kPSCs and not by BM-MSCs.Moreover, after blocking of the HGF-
receptor, the effect of hkPSCs on wound healing was diminished.
HGF has long been recognized as an important factor in kidney
regeneration and attenuation of renal fibrosis in several different
animal models [34]. HGF is primarily produced in nonepithelial
cells, such as fibroblasts and pericytes, and is able to block myofi-
broblast activation and therefore renal fibrosis. Moreover, HGF
can prevent tubular epithelial cell death both in vitro and in vivo,
the latter resulting in improved renal function after acute kidney
injury [35–37]. HGF is most likely also important in human kidney
regeneration, because a high expression of HGF in protocol biop-
sies after kidney transplantation correlated with lower levels of
fibrosis [38].
Although this study is not the first to describe an MSC-like
population in the human kidney [39], hkPSCs isolated through
thecurrent protocol represent adistinct population. Resident kid-
ney MSCs, as described by Bruno et al. [39], were isolated from
the glomeruli, whereas the hkPSCs described in the current pro-
tocol were isolated on the basis of NG2 expression. Because NG2
ismainly expressed around the large vessels (Fig. 2A), this is more
likely to represent a different perivascular population. Another
major difference is that hkPSCs are not positive for CD24, Pax2,
Oct4, or NANOG (supplemental online Fig. 1) and are, in contrast
to glomerular MSCs, not able to differentiate into adipocytes.
The differences between human kPSCs and BM-MSCs men-
tioned above may reflect differences in imprinting by the tissue
oforigin. Thiswaspreviously alsoobserved for fibroblasts isolated
from different organs [40]. In the current study, the expression
profile of homeobox genes, which are important for anatomical
patterning, showed a differential upregulation of HoxD10 and
HoxD11 expression by hkPSC, with the latter gene in the top five
most differentially expressed genes. Both Hox10 and Hox11 are
crucial for nephrogenesis. Hox10 genes function in the differen-
tiation and integration of the FoxD1+ renal cortical stroma, and
Hox11 genes are expressed in the metanephric mesenchyme.
Loss of either Hox10 or Hox11 gene function results in the loss
of ureteric bud induction, reduced branching, and decreased
nephrogenesis, phenotypes only described for Hox10 and 11mu-
tants and not for other Hoxmutants [24, 25]. This potential tissue
“memory of origin”may be reflected in the observed differences
in potential to integrate back into the kidney when injected into
the renal parenchyma. Such integration was never observed for
the bonemarrowMSCs, while the hkPSCsmigrated into the renal
interstitium and survived. Althoughwe observed integration into
the cortical interstitial compartment, we did not observe any in-
tegration into the epithelium. Previously, it was reported that
murine kidney-derivedMSC-like cells can integrate into thedevel-
oping collecting duct. However, the human kPSCs were isolated
from the perivascular fraction on the basis of NG2 expression,
while Li et al. isolatedmurineMSC-like cells on the basis of HoxB7
expression and thus the collecting duct epithelial compartment
[16]. When looking at the expression pattern of the homeobox
factors, HoxB7 expression in the human kPSCs was low, and
HoxD11 expression was high, suggesting a different origin likely
reflected in their distinct integration capacity and function. It re-
mains possible that a human kidney MSC-like population similar
to that isolated from mouse or reciprocally a murine kPSC popu-
lation similar to the hkPSC described here may exist.
Interestingly, hkPSCswere able to integrate back into the renal
interstitium and reduce the severity of kidney injury in vivo in a
rhabdomyolysis model. This was independent of the route of
delivery because both subcapsular and intravenously injected
hkPSCs were able to preserve renal function. However, with the
subcapsular injections, integration of the hkPSCs into the intersti-
tiumappearedmorepronounced, as did the renoprotective effect.
Whether human kPSCs are more suitable for cell therapy for
kidney diseases than BM-MSCs, which are currently studied in
clinical trials, still remains to be further elucidated. Their capacity
to reintegrate into the renal stroma, to improve tubular epithelial
wound repair, and to preserve function in an AKI model would
suggest that hkPSCs may have an organotypic role in maintaining
and restoring renal interstitial homeostasis without showing the
risk of increasing fibrosis. To be able to compare these cell types
for future cell therapy purposes, we chose to isolate the hkPSCs
with a SOP in a clinical-grade manner, with clinical-grade en-
zymes, materials, and methods that would allow direct transla-
tion into a clinical product. Using this protocol, one can obtain
large quantities of clinical-grade isolated hkPSCs. The yield from
onehumankidneywouldbeanaverageof 2.731012 hkPSCs after
passage 6. Hence, one donor kidney could yield a sufficient num-
ber of hkPSCs for the treatment of several different patients as a
cell therapy. This makes human kPSCs an interesting new cell
source to develop for regenerative medicine for kidney diseases.
CONCLUSION
These data show that human kPSCs show distinct functional prop-
erties in comparison with BM-MSCs with respect to growth factor
excretion, interstitial integration,andameliorationofkidney injury,
suggesting significant potential for hkPSCs and their secretome as
therapeutic candidates for the treatment of kidney disease.
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